| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cdcb9ac23b81ed41836bec14737d925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2035f3eefd6ea0911845fca1e4f4b1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd713b25c9645844ab8434cbb1a82efd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-56308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-56366 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0263
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02755 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 |
| filingDate |
2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0425d289c5fb472d70c3004118d4fb0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b81c0039353af70f0e44b7ea8cbede9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_960e246e7d78b9ba258eb523ffc58516 |
| publicationDate |
2012-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012095328-A1 |
| titleOfInvention |
System, method and computer-accessible medium for utilizing cardiac output to improve measurement of tracer input function in dynamic contrast-enhanced magnetic resonance imaging |
| abstract |
Exemplary embodiments of method, system and computer-accessible medium according to the present disclosure can be provided for converting magnetic resonance (MR) arterial signal intensity versus time curves to arterial input functions (AIF) with less susceptibility to artifacts such as flow-related enhancement. Exemplary methods, systems and computer-accessible medium can be used to constrain AIF to satisfies the indicator dilution principle, according to which the area under an initial pass component of AIF can be equal to the injected dose divided by the cardiac output. For example, Monte Carlo simulations of MR renography and tumor perfusion protocols can be performed for comparison with conventional methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013324845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016187146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018140217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7243973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849528-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017089997-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020065783-A |
| priorityDate |
2009-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |